Pentokey Organy (India) (BSE 524210)₹28.07−0.71%Commodity Chemicals
In the Mar 2026 quarter (standalone), Pentokey Organy (India) reported sales of −₹1.85 Cr, down 408.3% from Mar 2025, and net profit of −₹0.12 Cr, down 271.4% year on year. For the year to Mar 2026, sales were ₹2.08 Cr and net profit ₹0.19 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.29 | 2.06 | 0.02 | 0.00 | 0.00 | 0.21 | 0.00 | 0.60 | 5.05 | 0.97 | −2.08 | −1.85 |
| Expenses | 1.98 | 1.83 | 0.11 | 0.08 | 0.09 | 0.27 | 0.07 | 0.64 | 4.63 | 0.96 | −1.72 | −1.56 |
| Operating Profit | 0.34 | 0.26 | −0.06 | −0.06 | −0.09 | −0.03 | −0.07 | −0.03 | 0.43 | 0.04 | −0.37 | −0.32 |
| OPM % | 14.3% | 12.1% | −233.3% | — | — | −18.2% | — | −3.3% | 8.7% | 3.1% | — | — |
| Other Income | 0.12 | 0.10 | 0.10 | 0.11 | 0.12 | 0.14 | 0.09 | 0.07 | 0.03 | 0.10 | 0.08 | 0.17 |
| Interest | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.44 | 0.37 | 0.05 | 0.06 | 0.06 | 0.12 | 0.05 | 0.07 | 0.49 | 0.15 | −0.30 | −0.14 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | 0.44 | 0.37 | 0.03 | 0.04 | 0.04 | 0.10 | 0.05 | 0.07 | 0.49 | 0.13 | −0.28 | −0.12 |
| EPS (Rs) | 0.70 | 0.58 | 0.07 | 0.09 | 0.09 | 0.19 | 0.07 | 0.11 | 0.78 | 0.23 | −0.47 | −0.22 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 85.22 | 0.75 | 4.69 | 9.27 | 1.55 | 0.00 | 0.00 | 4.36 | 4.39 | 0.82 | 2.08 | 2.09 |
| Expenses | 88.72 | 2.60 | 5.32 | 10.11 | 2.26 | 0.55 | 0.42 | 3.53 | 3.97 | 1.05 | 2.31 | 2.31 |
| Operating Profit | −3.21 | −1.82 | −0.60 | −0.82 | −0.68 | −0.53 | −0.40 | 0.86 | 0.43 | −0.22 | −0.22 | −0.22 |
| OPM % | −3.8% | −240.8% | −13.0% | −8.7% | −44.3% | — | — | 19.5% | 10.0% | −25.3% | −10.0% | −10.5% |
| Other Income | 0.24 | 14.77 | 0.97 | 1.16 | 0.24 | 0.29 | 0.24 | 2.35 | 0.44 | 0.45 | 0.40 | 0.38 |
| Interest | 3.71 | 2.20 | 0.27 | 0.06 | 0.00 | 0.00 | 0.00 | 0.04 | 0.02 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.63 | 0.64 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −7.31 | 10.16 | 0.06 | 0.32 | −0.45 | −0.25 | −0.17 | 3.19 | 0.89 | 0.26 | 0.21 | 0.20 |
| Tax % | 22.5% | 5.3% | 80.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Exceptional items | 0.07 | 13.92 | 0.78 | 0.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −8.93 | 9.60 | 0.00 | 0.30 | −0.45 | −0.23 | −0.15 | 3.17 | 0.87 | 0.26 | 0.19 | 0.22 |
| EPS (Rs) | −14.27 | 15.33 | 0.03 | 0.50 | −0.71 | −0.39 | −0.27 | 5.08 | 1.41 | 0.41 | 0.33 | 0.32 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.28 | 6.26 | 6.26 | 6.27 | 6.28 | 6.27 | 6.28 | 6.28 | 6.27 | 6.27 | 6.28 | 6.28 |
| Reserves | −1.24 | −10.16 | −0.56 | −0.54 | −0.22 | −0.67 | −0.90 | −1.06 | 2.11 | 2.98 | 3.17 | 3.41 |
| Borrowings | 27.35 | 18.03 | 6.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 17.94 | 6.95 | 3.63 | 0.47 | 0.87 | 0.49 | 0.14 | 0.04 | 0.54 | 0.24 | 0.34 | −0.25 |
| Total Liabilities | 50.33 | 21.08 | 15.85 | 6.20 | 6.93 | 6.09 | 5.52 | 5.26 | 8.92 | 9.49 | 9.79 | 9.44 |
| Fixed Assets | 9.44 | 10.39 | 0.13 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.04 | 0.05 | 1.25 | 1.28 |
| Other Assets | 40.35 | 10.69 | 15.72 | 6.16 | 6.88 | 6.05 | 5.47 | 5.21 | 8.88 | 9.44 | 8.54 | 8.16 |
| Inventories | 14.30 | 0.42 | 0.12 | 0.09 | 0.29 | 0.00 | 0.00 | 0.00 | 0.22 | 0.00 | 0.34 | 0.34 |
| Trade receivables | 8.88 | 0.20 | 0.00 | 0.21 | 2.21 | 0.97 | 0.00 | 0.00 | 0.16 | 1.90 | 0.30 | 1.17 |
| Cash & equivalents | 1.71 | 0.47 | 0.18 | 2.13 | 2.73 | 3.79 | 4.59 | 4.35 | 4.49 | 5.47 | 4.88 | 6.03 |
| Total Assets | 50.33 | 21.08 | 15.85 | 6.20 | 6.93 | 6.09 | 5.52 | 5.26 | 8.92 | 9.49 | 9.79 | 9.44 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.09 | 12.47 | −3.00 | 8.33 | −1.96 | 0.87 | 0.57 | −0.43 | −0.11 | 0.56 | 0.23 | 0.77 |
| Cash from investing activity | 0.50 | −0.20 | 15.93 | −0.60 | 1.69 | −0.90 | −0.56 | 0.24 | 0.18 | −0.60 | −0.21 | −0.73 |
| Cash from financing activity | −0.71 | −12.45 | −13.19 | −7.31 | −0.02 | 0.00 | 0.00 | 0.00 | −0.04 | −0.02 | 0.00 | 0.00 |
| Net cash flow | −0.12 | −0.16 | −0.22 | 0.41 | −0.24 | −0.02 | 0.00 | −0.18 | 0.05 | −0.03 | 0.00 | 0.03 |
| Capex | 0.59 | 1.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free cash flow | −0.51 | 11.11 | 12.92 | 9.20 | 0.47 | 0.85 | 0.55 | −0.41 | −0.09 | 0.54 | 0.21 | 0.75 |
| CFO / OP % | −11.0% | −385.9% | 154.1% | −1,425.9% | 238.1% | −128.0% | −100.0% | 98.1% | −13.0% | 127.0% | −124.0% | −342.9% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 27 | 1 | 0 | 16 | 86 | 225 | — | — | 13 | 157 | 128 | 203 |
| Inventory days | 52 | 3 | 94 | 8 | 12 | 0 | — | — | 25 | 0 | 168 | 63 |
| Days payable | 53 | 15 | 491 | 22 | 26 | — | — | — | 45 | — | 65 | −52 |
| Cash conversion cycle | 24 | −12 | −398 | 0 | 72 | 226 | — | — | −8 | 158 | 230 | 317 |
| Working capital days | 4 | −17 | 5,249 | 227 | 122 | 299 | — | — | 284 | 270 | 1,245 | 375 |
| ROCE % | −2.8% | −15.8% | −16.4% | −5.4% | −10.3% | −7.5% | −4.3% | −3.0% | 47.3% | 10.1% | 2.7% | 2.1% |
For the Mar 2026 quarter, Pentokey Organy (India) reported sales of −₹1.85 Cr, down 408.3% year on year and net profit of −₹0.12 Cr, down 271.4% year on year.
Pentokey Organy (India)'s sales for the year to Mar 2026 were ₹2.08 Cr; over the last twelve months they were ₹2.09 Cr.
Net profit for the year to Mar 2026 was ₹0.19 Cr, and ₹0.22 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.32.
Pentokey Organy (India) reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹6.03 Cr.
Cash from operations was ₹0.77 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.75 Cr.